Atazanavir/ritonavir
- Level
- Commodity
- Parent
- 51343800
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51343822Definition: This classification denotes a combination drug for treatment of HIV. The first component, ATAZANAVIR is a protease inhibitor with a US FDA Unique Ingredient Identifier of QZU4H47A3S. ATAZANAVIR is an International Non-Proprietary Name or INN. The second component, RITONAVIR, is a pharmacokinetic booster with a US FDA Unique Ingredient Identifier of O3J8G9O825. RITONAVIR is an International Non-Proprietary Name or INN.
Same parent
Under 51343800 · 28Activities that produce or sell this
KBLI · 8Inherited from family 51340000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.